Peptable

Comparison

BPC-157 vs KPV

Also see:

BPC-157KPV

Function

While BPC-157 is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects111, KPV is investigated as an anti-inflammatory and barrier-protective agent in skin and mucosal models, reducing pro-inflammatory cytokines and promoting tissue repair684.

Mechanism

While BPC-157 works as a synthetic 15-amino-acid fragment of a gastric cytoprotective protein that promotes angiogenesis and tissue protection primarily by modulating VEGFR2 signaling, Src/caveolin-1–dependent eNOS activation, and nitric oxide production111, KPV is the C-terminal Lys-Pro-Val tripeptide fragment of α-MSH, which exerts potent anti-inflammatory effects largely via inhibition of NF-κB signaling and modulation of cytokine expression, with many actions independent of classical melanocortin receptor activation684.

Receptor

BPC-157

VEGFR2 (vascular endothelial growth factor receptor 2) on endothelial cells, with downstream eNOS and nitric-oxide–mediated signaling11

KPV

No single primary receptor; the KPV motif can influence melanocortin receptor binding profiles (MC1R–MC5R), but many anti-inflammatory effects appear melanocortin-independent684

Organism or Origin

BPC-157

Synthetic peptide derived from a naturally occurring human gastric 'Body Protection Compound' isolated from human gastric juice111

KPV

Endogenous tripeptide corresponding to positions 11–13 of human α-MSH8490

Gene

BPC-157

Not assigned in the current dataset.

KPV

POMC

Summary

Both peptides fall into a similar broad context as Signal peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Gastroenterology and Dermatology and aesthetics contexts, while BPC-157 is more of a signal peptide and KPV is better described as a immune-modulating peptide. Both appear to work through Signaling modulator, but the functional emphasis still separates, with BPC-157 leaning toward Tissue repair and healing and Angiogenesis modulation and KPV leaning toward Immune regulation. BPC-157 has a more synthetic analog origin, while KPV is closer to natural endogenous background and both are still best understood as being in Preclinical development. Their sequence patterns also diverge, with BPC-157 showing proline-rich features and KPV showing protein-mimetic sequence features.

Sources

11BPC-157 - Wikipedia, https://en.wikipedia.org/wiki/BPC-157
6Keratinocyte And Dermal..., https://oathresearch.com/2026/03/27/kpv-tripeptide-nfkb-inhibition-anti-inflammatory-mechanisms-cell-culture/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/